Official Title: A Phase III Open-Label, Single-Group, Extension Study to Obtain Long-Term Safety and Tolerability Data of Idebenone in the Treatment of Friedreich's Ataxia Patients.
This study is currently recruiting participants.
Verified by Santhera Pharmaceuticals, October 2009
First Received: October 13, 2009
Sponsored by: Santhera Pharmaceuticals
ClinicalTrials.gov Identifier: NCT00993967
Wednesday, October 14, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment